Rhizochalinin (Rhiz), a cytotoxic sphingolipid, impedes proliferation in glioblastoma cells by promoting apoptosis, arresting the cell cycle at the G2/M phase, and inhibiting autophagy, making it a valuable agent for human glioblastoma studies [1].